A prospective, multicenter cancer clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) has validated an ...
The 2025 San Antonio Breast Cancer Symposium brought plenty of data and bold new ideas to the thousands of clinicians, ...
In November 2025, Rana McKay, MD initiated a phase 2 study of the combination of cabozantinib + nivolumab in subjects with advanced castration-resistant prostate cancer (CRPC). DelveInsight's Bone ...
Metastatic breast cancer (MBC) or stage IV breast cancer is when cancer spreads beyond the breast and regional lymph nodes to distant sites like bones, liver, lungs or brain. Breast cancer cells ...
Metastatic cancer, the form of cancer that spreads from its original site to distant parts of the body, often provides warning signs long before diagnosis. These signals, frequently dismissed as ...
SABCS 2025 analysis shows persistent racial and socioeconomic gaps in metastatic HR+/HER2 negative breast cancer diagnosis ...
Elacestrant combined with everolimus or abemaciclib showed significant PFS benefits in ER-positive, HER2-negative metastatic breast cancer patients. The ELEVATE trial reported median PFS of 8.3 months ...
Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback